Cargando…

Patterns of Medication Exposure in Children on Extracorporeal Membrane Oxygenation: A Step in Prioritizing Future Pharmacologic Studies

To identify medications administered to pediatric patients on extracorporeal membrane oxygenation and to review the available pharmacokinetics and pharmacodynamics literature for the most commonly administered medications. DESIGN: Retrospective single-center study. SETTING: ICUs at Children’s Hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Thibault, Céline, Collier, Hailey, Naim, Maryam Y., Heichel, Jenna, Schwartz, Emily, Zuppa, Athena F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063935/
https://www.ncbi.nlm.nih.gov/pubmed/32166287
http://dx.doi.org/10.1097/CCE.0000000000000045
_version_ 1783504784932732928
author Thibault, Céline
Collier, Hailey
Naim, Maryam Y.
Heichel, Jenna
Schwartz, Emily
Zuppa, Athena F.
author_facet Thibault, Céline
Collier, Hailey
Naim, Maryam Y.
Heichel, Jenna
Schwartz, Emily
Zuppa, Athena F.
author_sort Thibault, Céline
collection PubMed
description To identify medications administered to pediatric patients on extracorporeal membrane oxygenation and to review the available pharmacokinetics and pharmacodynamics literature for the most commonly administered medications. DESIGN: Retrospective single-center study. SETTING: ICUs at Children’s Hospital of Philadelphia. PATIENTS: Pediatric patients supported by extracorporeal membrane oxygenation between October 1, 2014, and September 30, 2018. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Drug exposure was described according to age group (< 1 mo, 1 mo to < 2 yr, 2 to < 12 yr, and > 12 yr) and ICU (cardiac, neonatal, pediatric). The association of drug exposure with patient’s characteristics was examined using one-way analysis of variance for categorical variables and linear regression for continuous variables. All pharmacokinetics and pharmacodynamics literature for the 50 most commonly administered medications on extracorporeal membrane oxygenation was reviewed, with inclusion of studies that reported dosing regimens in conjunction with pharmacokinetics or pharmacodynamics data. A total of 179 different medications were administered to 254 children. Cumulative drug exposure increased with the duration of extracorporeal membrane oxygenation from a median (interquartile) of 10 drugs (6–14) at 1 week to 31 drugs (21–45) at 5 weeks following cannulation. There were significant differences in total drug exposure between age groups and ICUs. With exclusion of in vitro studies, published literature was available to support the use of 40% (20/50) of the most commonly administered medications. Dosing guidance was available for 20% (10/50) of medications and was primarily based on simulations and retrospective studies focusing on neonates and infants. CONCLUSIONS: This study highlights specific needs for future pharmacokinetics and pharmacodynamics studies. Dosing guidelines are essential to optimize the care of critically ill children supported by extracorporeal membrane oxygenation.
format Online
Article
Text
id pubmed-7063935
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-70639352020-03-12 Patterns of Medication Exposure in Children on Extracorporeal Membrane Oxygenation: A Step in Prioritizing Future Pharmacologic Studies Thibault, Céline Collier, Hailey Naim, Maryam Y. Heichel, Jenna Schwartz, Emily Zuppa, Athena F. Crit Care Explor Observational/Cohort Study To identify medications administered to pediatric patients on extracorporeal membrane oxygenation and to review the available pharmacokinetics and pharmacodynamics literature for the most commonly administered medications. DESIGN: Retrospective single-center study. SETTING: ICUs at Children’s Hospital of Philadelphia. PATIENTS: Pediatric patients supported by extracorporeal membrane oxygenation between October 1, 2014, and September 30, 2018. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Drug exposure was described according to age group (< 1 mo, 1 mo to < 2 yr, 2 to < 12 yr, and > 12 yr) and ICU (cardiac, neonatal, pediatric). The association of drug exposure with patient’s characteristics was examined using one-way analysis of variance for categorical variables and linear regression for continuous variables. All pharmacokinetics and pharmacodynamics literature for the 50 most commonly administered medications on extracorporeal membrane oxygenation was reviewed, with inclusion of studies that reported dosing regimens in conjunction with pharmacokinetics or pharmacodynamics data. A total of 179 different medications were administered to 254 children. Cumulative drug exposure increased with the duration of extracorporeal membrane oxygenation from a median (interquartile) of 10 drugs (6–14) at 1 week to 31 drugs (21–45) at 5 weeks following cannulation. There were significant differences in total drug exposure between age groups and ICUs. With exclusion of in vitro studies, published literature was available to support the use of 40% (20/50) of the most commonly administered medications. Dosing guidance was available for 20% (10/50) of medications and was primarily based on simulations and retrospective studies focusing on neonates and infants. CONCLUSIONS: This study highlights specific needs for future pharmacokinetics and pharmacodynamics studies. Dosing guidelines are essential to optimize the care of critically ill children supported by extracorporeal membrane oxygenation. Wolters Kluwer Health 2019-09-16 /pmc/articles/PMC7063935/ /pubmed/32166287 http://dx.doi.org/10.1097/CCE.0000000000000045 Text en Copyright © 2019 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Observational/Cohort Study
Thibault, Céline
Collier, Hailey
Naim, Maryam Y.
Heichel, Jenna
Schwartz, Emily
Zuppa, Athena F.
Patterns of Medication Exposure in Children on Extracorporeal Membrane Oxygenation: A Step in Prioritizing Future Pharmacologic Studies
title Patterns of Medication Exposure in Children on Extracorporeal Membrane Oxygenation: A Step in Prioritizing Future Pharmacologic Studies
title_full Patterns of Medication Exposure in Children on Extracorporeal Membrane Oxygenation: A Step in Prioritizing Future Pharmacologic Studies
title_fullStr Patterns of Medication Exposure in Children on Extracorporeal Membrane Oxygenation: A Step in Prioritizing Future Pharmacologic Studies
title_full_unstemmed Patterns of Medication Exposure in Children on Extracorporeal Membrane Oxygenation: A Step in Prioritizing Future Pharmacologic Studies
title_short Patterns of Medication Exposure in Children on Extracorporeal Membrane Oxygenation: A Step in Prioritizing Future Pharmacologic Studies
title_sort patterns of medication exposure in children on extracorporeal membrane oxygenation: a step in prioritizing future pharmacologic studies
topic Observational/Cohort Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063935/
https://www.ncbi.nlm.nih.gov/pubmed/32166287
http://dx.doi.org/10.1097/CCE.0000000000000045
work_keys_str_mv AT thibaultceline patternsofmedicationexposureinchildrenonextracorporealmembraneoxygenationastepinprioritizingfuturepharmacologicstudies
AT collierhailey patternsofmedicationexposureinchildrenonextracorporealmembraneoxygenationastepinprioritizingfuturepharmacologicstudies
AT naimmaryamy patternsofmedicationexposureinchildrenonextracorporealmembraneoxygenationastepinprioritizingfuturepharmacologicstudies
AT heicheljenna patternsofmedicationexposureinchildrenonextracorporealmembraneoxygenationastepinprioritizingfuturepharmacologicstudies
AT schwartzemily patternsofmedicationexposureinchildrenonextracorporealmembraneoxygenationastepinprioritizingfuturepharmacologicstudies
AT zuppaathenaf patternsofmedicationexposureinchildrenonextracorporealmembraneoxygenationastepinprioritizingfuturepharmacologicstudies